Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health
horizonal rule

Consumer (CDRH/FDA) (Consumer Photo Montage)
Skip Consumer NavigationConsumer Home Product Information Choosing a Medical Device How We Can Help Resources Problems with Medical Devices

(See Related Information)
New Device Approval

Photo of ACCULINK Ste tACCULINK™ Carotid Stent System
RX ACCULINK™ Carotid Stent System - P040012

This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.


Product Name: ACCULINK™ and RX ACCULINK™ Carotid Stent System
Applicant: Guidant Corporation
Address: Mailstop S216, 3200 Lakeside Drive, Santa Clara, CA 95054
Approval Date: August 30, 2004
Approval Letter: http://www.fda.gov/cdrh/pdf4/p040012a.pdf

What is it? This device has two systems: the stent and delivery catheter system (ACCULINK™ and RX ACCULINK™ Carotid Stent System) used with an embolic protection system (ACCUNET™ and RX ACCUNET™ EPS). The stent is a metal mesh tube on a delivery catheter. The embolic protection device is a micromesh filter basket on the end of a delivery catheter that catches any particles that may break off from the blockage during the operation.

How does it work? A Carotid Stent System is inserted during angioplasty, a less invasive procedure in which the stent is threaded up to the neck artery via a catheter inserted in the groin.

When is it used? The Carotid Stent Systems are used in patients who:

What will it accomplish? A clinical study of 581 patients showed that the new stent system successfully opened blockages in 92 percent of patients. When complications from use of the stent were compared to complications reported in the medical literature from patients undergoing surgery, the risk of combined complications of death, stroke and heart attack at 30 days or stroke in the area of the blockage at one year was about 10% compared to 15% for surgery. In addition, the study showed that the stent still allowed blood flow to the brain more than two years after the procedure.

When should it not be used? The Carotid Stent Systems should not be used in patients who:

Additional information: Summary of Safety and Effectiveness and labeling will be available at: http://www.fda.gov/cdrh/pdf4/p040012.html

Other:
FDA Talk Paper:
http://www.fda.gov/bbs/topics/news/2004/NEW01111.html

Illustration of the carotid artery:
http://www.nlm.nih.gov/medlineplus/ency/imagepages/9552.htm

Interactive tutorial on preventing strokes:
http://www.nlm.nih.gov/medlineplus/tutorials/preventingstrokes.html

Interactive tutorial on carotid endarterectomy:
http://www.nlm.nih.gov/medlineplus/tutorials/carotidendarterectomy.html

Interactive tutorial on angioplasty:
http://www.nlm.nih.gov/medlineplus/tutorials/coronaryangiographyandangioplasty.html

Updated September 20, 2004

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH